Filtros de búsqueda

Lista de obras de Mette Julsgaard

Adalimumab levels in an infant ⬇️

artículo científico publicado el 25 de octubre de 2012

Adherence and quality of care in IBD.

artículo científico publicado en 2016

Adherence to medical treatment in relation to pregnancy, birth outcome & breastfeeding behavior among women with Crohn's disease

artículo científico publicado en 2016

Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes

artículo científico publicado en 2020

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

artículo científico publicado en 2016

Development of a Sexual Dysfunction Scale for Women With Inflammatory Bowel Disease

scientific article published on 01 October 2018

Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study

artículo científico publicado en 2018

Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.

artículo científico publicado en 2017

Immunoglobulin and Infliximab Concentrations in Dichorionic Twins Exposed to Infliximab in Utero.

artículo científico publicado en 2017

Infliximab concentrations in the milk of nursing mothers with inflammatory bowel disease

artículo científico publicado en 2013

Influence of medical treatment, smoking and disease activity on pregnancy outcomes in Crohn's disease.

artículo científico publicado en 2014

Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease

artículo científico publicado en 2018

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.

artículo científico publicado en 2018

Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease

scientific article published on 27 February 2019

Pregnancy outcome in four women with inflammatory bowel disease treated with budesonide MMX

scientific article published on 01 December 2018

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study

artículo científico publicado en 2019

Reply

Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis.

artículo científico publicado en 2010

Self-reported adherence to medical treatment, breastfeeding behaviour, and disease activity during the postpartum period in women with Crohn's disease

artículo científico publicado en 2014

Semen Quality and Sperm DNA Integrity in Patients With Severe Active Inflammatory Bowel Disease and Effects of Tumour Necrosis Factor-alpha Inhibitors

artículo científico publicado en 2019

Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men with Inflammatory Bowel Disease

artículo científico publicado en 2019

Submandibular Sialoadenitis in an Infant Exposed to Adalimumab and Infliximab in Utero

artículo científico publicado en 2017

Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study]

artículo científico publicado en 2022

Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease.

artículo científico publicado en 2017

Vedolizumab Does Not Impair Sperm DNA Integrity in Men With Inflammatory Bowel Disease

artículo científico publicado en 2019

Vedolizumab safety in pregnancy and newborn outcomes.

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda